|Articles|November 21, 2019
Challenging Microbial Sanitization of a Liquid Chromatography System
To ensure that no contaminating or hazardous residual components remain after protein purification during biologic development, additional sanitization steps may be required for the instrumentation utilized during these processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Agentic AI in Drug Discovery
2
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
3
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5